Related Experiment Video
Updated: Apr 26, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
14.2K
Diffuse large B-cell lymphoma: the history, current view and new perspectives
Neoplasma
|July 18, 2014
Summary
Lymphoma classification is evolving with new hematooncology insights, improving diagnostics and targeted therapies. Diffuse large B-cell lymphoma
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Lymphoma classification has evolved significantly over decades.
- Contemporary hematooncology advances impact diagnostic and prognostic algorithms.
- New insights enable targeted and tailored lymphoma therapies.
Purpose of the Study:
- To describe the heterogeneity of diffuse large B-cell lymphoma (DLBCL).
- To relate DLBCL heterogeneity to the World Health Organization (WHO) classification (2008).
- To discuss the potential influence of new knowledge on DLBCL classification and therapy.
Main Methods:
- Review of clinical, morphological, and molecular data.
- Analysis of lymphoproliferations in the context of lymphocytic and lymphoid development.
- Examination of the heterogeneity of diffuse large B-cell lymphoma.
Main Results:
- Significant heterogeneity exists within diffuse large B-cell lymphoma.
- The 2008 WHO classification provides a framework for understanding DLBCL.
- Ongoing research continues to refine our understanding of DLBCL.
Conclusions:
- Understanding lymphoma heterogeneity is crucial for accurate diagnosis and prognosis.
- Advances in hematooncology are driving personalized treatment strategies.
- Further research into DLBCL pathogenesis and biology will advance classification and therapy.
More Related Videos
Related Concept Videos
Primary Lymphoid Organs
9.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
9.6K
Lymphoid Cells and Tissues
3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Secondary Lymphoid Organs
7.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.2K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
B Cell Activation and Differentiation
14.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K

